Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis

The Lancet

Volumn 373, Issue 9658, 2009, Pages 137-146

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT THERAPY; ARTICLE; BRACHYTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CLINICAL FEATURE; CLINICAL TRIAL; ENDOMETRIUM CANCER; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HAZARD RATIO; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PELVIS; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZATION; RECURRENCE RISK; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW;

EID: 58149186453     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61767-5     Document Type: Article

References (10)

1. Kong A., Simera I., Collingwood M., Williams C., Kitchener H., and on behalf of Cochrane Gynaecological Cancer Group. Adjuvant radiotherapy for stage I endometrial cancer: systematic review and meta-analysis. Ann Oncol 18 (2007) 1595-1604
2. Aalders J., Abeler V., Kolstad P., et al. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 56 (1980) 419-427
3. Soderini A., and Sardi J. Role of adjuvant radiotherapy in intermediate risk (Ib G2-3-IC) endometriod carcinoma after extended staging surgery. Preliminary reports of a randomised trial. Int J Gynecol Cancer 13 suppl 1 (2003) 78
4. Keys H.M., Roberts J.A., Brunetto V.L., et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 92 (2004) 744-751
5. Creutzberg C.L., van Putten W.L., Koper P.C., et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage 1 endometrial carcinoma: multi centre trial. PORTEC study group. Lancet 355 (2000) 1404-1411
6. Shepherd J.H. Revised FIGO staging for gynaecological cancer. Br J Obstet Gynecol 96 (1989) 889-892
7. Standards and Minimum Datasets for Reporting Cancers. Minimum dataset for the histopathological reporting of atypical hyperplasia and adenocarcinoma in endometrial biopsy and curettage specimens and for endometrial cancer in hysterectomy specimens (2001), Royal College of Pathologists
8. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Engl J Med 333 (1995) 1444-1455
9. Royston P., and Parmar M.K. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med 21 (2002) 2175-2197
10. Lefebvre C., and Clarke M. Identifying randomised trials. In: Egger M.S.G., and Altman D.G. (Eds). Systematic reviews in healthcare: meta-analysis in context. 2nd edn. (2001), BMJ Publishing Group, London 69-87